(1)
Efficacy of Dual Therapy in Patients >65 Years Old With Alanine Transaminase Flare During Chronic Hepatitis C Genotype 2. Ital J Med 2015, 9 (1), 82-88. https://doi.org/10.4081/itjm.2015.471.